Richard F. Riedel

NCCN Guidelines Insights: Soft Tissue Sarcoma, Version 1.2021.

J. Sicklick, S. Dry, M. McCarter, 2020, Journal of the National Comprehensive Cancer Network : JNCCN.

A Phase I Trial of the IGF-1R Antibody Ganitumab (AMG 479) in Combination with Everolimus (RAD001) and Panitumumab in Patients with Advanced Cancer.

H. Hurwitz, R. Riedel, H. Pang, 2018, The oncologist.